Increased tumor necrosis factor-alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia

Psychiatry Research

Volumn 160, Issue 3, 2008, Pages 256-262

  O'Brien, Sinead M ^a   Scully, Paul ^a   Dinan, Timothy G ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Cytokine; ELISA; Interleukin; Plasma; Schizophrenia

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY; TH1 CELL; TH2 CELL;

ACUTE DISEASE; ADULT; CONTROL GROUPS; CYTOKINES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-4; INTERLEUKIN-8; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, INTERLEUKIN-2; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 50449086420     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2007.11.014     Document Type: Article

References (67)

1. Aghajanian G.K., and Marek G.J. Serotonin model of schizophrenia: emerging role of glutamate mechanisms. Brain Research. Brain Research Reviews 31 (2000) 302-312
2. Akiyama K. Serum levels of soluble IL-2 receptor alpha, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration. Schizophrenia Research 37 (1999) 97-106
3. Aldhahi W., and Hamdy O. Adipokines, inflammation and the endothelium in diabetes. Current Diabetes Reports 3 (2003) 293-298
4. Auphan N., DiDonato J.A., Rosette C., Helmberg A., and Karin M. Immunosuppression by glucocorticoids: inhibition of NFκB activity through induction of Iκ-B synthesis. Science 270 (1995) 286-290
5. Avgustin B., Wraber B., and Tavcar R. Increased Th1 and Th2 immune reactivity with relative Th2 dominance in patients with acute exacerbation of schizophrenia. Croatian Medical Journal 46 (2005) 268-274
6. Bagalkote H., Pang D., and Jones P.B. Maternal influenza and schizophrenia. International Journal of Mental Health 29 (2001) 3-21
7. Banki C., Bisette G., Arato M., O'Connor L., and Nemeroff C.B. CSF corticotrophin releasing factor-like immunoreactivity in depression and schizophrenia. American Journal of Psychiatry 144 (1987) 873-877
8. Barak V., Barak Y., Levine J., Nisman B., and Roisman I. Changes in interleukin-1 beta and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients. Journal of Basic and Clinical Physiology and Pharmacology 6 (1995) 61-69
9. Brown A.S., and Susser E.S. In utero infection and adult schizophrenia. Mental Retardation and Developmental Disability Research Reviews 8 (2002) 51-57
10. Brown A.S., Cohen P., Harkavy-Friedman J., Babulas V., Malaspina D., Gorman J.M., and Susser E.S. AE Bennett Research Award: prenatal rubella, premorbid abnormalities, and adult schizophrenia. Biological Psychiatry 49 (2001) 473-486
11. Brown A.S., Hooter J., Schaefer C.A., Zhang H., Petkova E., Babulas V., Perrin M., Gorman J.M., and Susser E.S. Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. American Journal of Psychiatry 161 (2004) 889-895
12. Cannon M., Jones P.B., and Murray R.M. Obstetric complications and schizophrenia. Historical and meta-analytic review. American Journal of Psychiatry 159 (2002) 1080-1092
13. Cazulla C.L., Sacchetti E., Galluzzo A., Panariello A., Colombo F., Zagliani A., and Clerici M. Cytokine profiles in drug-naive schizophrenic patients. Schizophrenia Research 47 (2001) 293-298
14. Cazzullo C.L., Sacchetti E., Galluzzo A., Panariello A., Adorni A., Pegoraro M., Bosis S., Colombo F., Trabattoni D., Zagliani A., and Clerici M. Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study. Progress in Neuro-psychopharmacology & Biological Psychiatry 26 (2002) 33-39
15. Demirjian L., Abboud R.T., Li H., and Duronio V. Acute effect of cigarette smoke on TNF-alpha release by macrophages mediated through the erk1/2 pathway. Biochimica et Biophysica Acta 1762 (2006) 592-597
16. Dentino A.N., Pieper C.F., Rao K.M.K., Currie M.S., Harris T., Blazer D.G., and Cohen H.J. Association of interleukin-6 and other biological variables with depression in older people living in the community. Journal of the American Geriatric Society 47 (1999) 6-11
17. Ebrinc S., Top C., Oncul O., Basoglu C., Cavuslu S., and Cetin M. Serum interleukin 1 alpha and interleukin 2 levels in patients with schizophrenia. Journal of International Medical Research 30 (2002) 314-317
18. Erbagci A.B., Herken H., Koyluoglu O., Yilmaz N., and Tarakcioglu M. Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment. Mediators of Inflammation 10 (2001) 109-115
19. First M.B., Spietzer R.L., Gibbon M., and William J.B.W. Structured Clinical Interview for DSM-1V axis 1 Disorders Clinical Version (1997), American Psychiatric Press, Washington, DC
20. Fleischmann R., and Yocum D. Does safety make a difference in selecting the right TNF antagonist?. Arthrithis Research and Therapy 6 Suppl. 2 (2004) S12-S18
21. Frommberger U.H., Bauer J., Haselbauer P., Fraulin A., Riemann D., and Berger M.O. Interleukin-6 (IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. European Archives of Psychiatry and Clinical Neuroscience 247 (1997) 228-233
22. Ganguli R., Yang Z., Shurin G., Chengappa K.N., Brar J.S., Gubbi A.V., and Rabin B.S. Serum interluekin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatry Research 51 (1994) 1-10
23. Garbutt J.C., and van Kaamen D.P. The interaction between GABA and dopamine: implications for schizophrenia. Schizophrenia Bulletin 9 (1983) 336-353
24. Gattaz W.F., Dalgalarrondo P., and Schroder H.C. Abnormalities in serum concentrations of interleukin-2, interferon-alpha and interferon-gamma in schizophrenia not detected. Schizophrenia Research 6 (1992) 237-241
25. Haack M., Hinze-Selch D., Fenzel T., Kraus T., Kuhn M., Schuld A., and Pollmacher T. Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. Journal of Psychiatric Research 33 (1999) 407-418
26. Inglot A.D., Leszek J., Piasecki E., and Sypula A. Interferon responses in schizophrenia and major depressive disorders. Biological Psychiatry 35 (1994) 464-473
27. Jones A.L., Mowry B.J., Pender M.P., and Greer J.M. Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis?. Immunology and Cell Biology 83 (2005) 9-17
28. Katsikis P.D., Cohen S.B., Londei M., and Feldmann M. Are CD4+Th1 cells pro-inflammatory or antiinflammatory? The ratio of IL-10 to IFN-gamma or IL-2 determines their function. International Immunology 7 (1995) 1287-1294
29. Kay S.R., Fiszbein A., and Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13 (1987) 261-267
30. Kenis G., and Maes M. Effects of antidepressants on the production of cytokines. International Journal of Neuropsychopharmacology 5 (2002) 401-412
31. Kim Y.K., Lee M.S., and Suh K.Y. Decreased interleukin-2 production in Korean schizophrenic patients. Biological Psychiatry 43 (1998) 701-704
32. Kim Y.K., Kim L., and Lee M.S. Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics. Schizophrenia Research 44 (2000) 165-175
33. Kim D.J., Kim W., Yoon S.J., Go H.J., Choi B.M., Jun T.Y., and Kim Y.K. Effect of risperidone on serum cytokines. International Journal of Neuroscience 111 (2001) 11-19
34. Kim Y.K., Suh I.B., Kim H., Han C.S., Lim C.S., Choi S.H., and Licinio J. The plasma levels of interleukin-12 in schizophrenia, major depression and bipolar mania: effects of psychotrophic drugs. Molecular Psychiatry 7 (2002) 1107-1114
35. Kim Y.K., Myint A.M., Lee B.H., Han C.S., Lee H.J., Kim D.J., and Leonard B.E. Th1, Th2 and Th3 cytokine alteration in schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry 28 (2004) 1129-1134
36. Kim Y.K., Myint A.M., Lee B.H., Han C.S., Lee S.W., Leonard B.E., and Steinbusch H.W. T helper types 1,2,3 interactions in symptomatic manic patients. Psychiatry Research 129 (2004) 267-272
37. Lacraz S., Nicod L., Galve-de Rocnemonteix B., Baumberger C., Dayer J.M., and Welgus H.G. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. The Journal of Clinical Investigation 90 (1992) 382-388
38. Lacraz S., Nicod L., Chicheportiche R., Welgus H.G., and Dayer J.M. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. The Journal of Clinical Investigation 96 (1995) 2304-2310
39. Lin A., Kenis G., Bignotti S., Tura G.J., De J.R., Bosmans E., Pioli R., Altamura C., Scharpe S., and Maes M. The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6. Schizophrenia Research 32 (1998) 9-15
40. Maes M., Bosmans E., Calabrese J., Smith R., and Meltzer H.Y. Interleukin-2 and Interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilisers. Journal of Psychiatric Research 29 (1995) 141-152
41. Maes M., Bocchio C.L., Bignotti S., Battisa T.G., Pioli R., Boin F., Kenis G., Bosmans E., De Jongh R., Lin A., Racagni G., and Altamura C.A. Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics. European Neuropsychopharmacology 10 (2000) 119-124
42. Maes M., Bocchio C.L., Bignotti S., Battisa Tura G.J., Pioli R., Boin F., Kenis G., Bosmans E., de Jongh R., and Altamura C.A. Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor. Schizophrenia Research 54 (2002) 281-291
43. Mittleman B.B., Castellanos F.X., Jacobsen L.K., Rapoport J.J., Swedo S.E., and Shearer G.M. Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease. Journal of Immunology 159 (1997) 2994-2999
44. Monteleone P., Fabrazzo M., Tortorella A., and Maj M. Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment. Psychiatry Research 16 (1997) 11-17
45. Mowry B.J., and Nancarrow D.J. Molecular genetics of schizophrenia. Clinical and Experimental pharmacology and physiology 28 (2001) 66-69
46. Mueser K.T., and McGurk S.R. Schizophrenia. Lancet 363 (2004) 2063-2072
47. Myint A.M., Leonard B.E., Steinbusch H.W., and Kim Y.K. Th1, Th2 and Th3 cytokine alterations in major depression. Journal of Affective Disorders 88 (2005) 167-173
48. Naudin J., Mege J.L., Azorin J.M., and Dassa D. Elevated circulating levels of IL-6 in schizophrenia. Schizophrenia Research 20 (1996) 269-273
49. Naudin J., Capo C., Giusano B., Mege J.L., and Azorin J.M. A differential role for interleukin-6 and tumor necrosis factor-α in schizophrenia. Schizophrenia Research 26 (1997) 227-233
50. Pae C.U., Yoon C.H., Kim T.S., Kim J.J., Park S.H., Lee C.U., Lee S.J., Lee C., and Paik I.H. Antipsychotic treatment may alter T-helper (TH) 2 arm cytokines. International Immunology, 6 (2006) 666-671
51. Romagnani S. Th1/Th2 cells. Inflammatory Bowel Diseases 5 (1999) 285-294
52. Rothermundt M., Arolt V., Weitzsch C., Eckhoff D., and Kirchner H. Immunological dysfunction in schizophrenia: a systematic approach. Neuropsychobiology 37 (1998) 186-193
53. Sampaio E.P., Sarno E.N., Galilly R., Cohn Z.A., and Kaplan G. Thalidomide selectively inhibits tumour necrosis factor alpha production by stimulating human monocytes. Journal of Experimental Medicine 173 (1991) 699-703
54. Scheinman R.I., Cogswell P.C., Lofquist A.K., and Baldwin Jr. A.S. Role of transcriptional activation of IκB in mediation of immunosuppression by glucocorticoids. Science. 270 (1995) 283-286
55. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1 (1987) 133-152
56. Song C., Lin A., Kenis G., Bosmans E., and Maes M. Immunosuppressive effects of clozapine and haloperidol: enhanced production of interleukin-1 receptor antagonist. Schizophrenia Research 42 (2000) 157-164
57. Stefanis C.N., Theodoropoulou-Vaidaki S., Baxevanis C.N., Spanakos G., Papadopoulos N.G., Economou M., and Papamichael M. Investigation of immune parameters in never medicated and chronically medicated schizophrenic patients. Neuropsychopharmacology 10 35 (1994) S80-S366
58. Theodoropoulou S., Spanakos G., Baxevanis C.N., Economou M., Gritzapis A.D., Papamichail M.P., and Stefanis C.N. Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients. Schizophrenia Research 47 (2001) 13-25
59. Thompson A.W., and Lotze M.T. The Cytokine Handbook. Fourth Edition (2003), Academic Press, London.
60. Van Cauter E., Linkowski P., Kerhofs M., Hubain P., L'Hermite-Baleriaux M., Leclerq R., Brasseur M., Copinshi G., and Mendlewicz J. Circadian and sleep related endocrine rhythms in schizophrenia. Archives of General Psychiatry 48 (1991) 348-356
61. Wilke I., Arnolt V., Rothermundt M., Weitzsch C., Hornberg M., and Kirchner H. Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients. European Archives of Psychiatry Clinical Neuroscience 246 (1996) 279-284
62. Xu H.M., Wei J., and Hemmings G.P. Changes of plasma concentrations of interleukin-1-alpha and interleukin-6 with neuroleptic treatment of schizophrenia. British Journal of Psychiatry 164 (1994) 251-253
63. Yang S.R., Chida A.S., Bauter M.R., Shafiq N., Seweryniak K., Maggirwar S.B., Kilty I., and Rahman I. Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. American Journal of Physiology. Lung Cellular Molecular Physiology 291 (2006) L46-L57
64. Yudkin J.S. Adipose tissue, insulin action and vascular disease: inflammatory signals. International Journal of Obesity and Related Metabolic Disorders 27 Suppl 3 (2003) S25-S28
65. Zhang X.Y., Zhou D.F., Zhang P.Y., Wu G.Y., Cao L.Y., and Shen Y.C. Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology. Schizophrenia Research 57 (2002) 247-258
66. Zhang X.Y., Zhou D.F., Cao L.Y., Zhang P.Y., and Wu G.Y. Decreased production of interleukin-2 (IL-2), IL-2 secreting cells and CD4+cells in medication-free patients with schizophrenia. Journal of Psychiatric Research 36 (2002) 331-336
67. Zhang X.Y., Zhou D.F., Chao L.Y., Wu G.Y., and Shen M.D. Changes in serum interleukin-2 -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia. Journal of Clinical Psychiatry 65 (2004) 940-947